Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis
Clinical trial NCT06881433 · COMPLETED
Trial details
- NCT number
- NCT06881433
- Sponsor
- Zhongda Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-06-01
- Primary completion
- 2024-12-31
- Enrollment
- 1649
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.